Literatur
-
1
Avontuur J AM, Buijk S LCE, Bruining H A.
Distribution and metabolism of
NG-nitro-L-arginine methyl ester in patients with septic shock.
Eur
J Clin Pharmacol.
1998;
54
627-631
-
2
Bachmann S, Bosse H M, Mundel P.
Topography
of nitric oxide synthesis by localizing constitutive NO synthases
in mammalian kidneys.
Am J Physiol.
1995;
268
F885-F998
-
3
Barba G, Vallance P J, Strazzullo P. et al .
Effects of sodium intake on the the pressor
and renal responses to nitric oxide synthesis inhibition in normotensive
individuals with different sodium sensitivity.
J Hypertens.
2000;
18
615-621
-
4
Barri Y M, Wilcox C S.
Salt intake
determines the renal response to L-arginine infusion in human subjects.
Kidney
Int.
1998;
53
1299-1304
-
5
Bayerle-Eder M, Fuchsjäger-Mayerl G, Sieder A. et al .
Effect of pravastatin on
responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia.
Atherosclerosis.
2002;
160
177-184
-
6
Bech J N, Nielsen C B, Pedersen E B.
Effects of systemic NO synthesis inhibition
on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Am
J Physiol.
1996;
270
F845-F851
-
7
Bech J N, Svedsen K B, Nielsen C B, Pedersen B P.
The
systemic renal response to NO inhibition is not modified by angiotensin-II-receptor
blockade in healthy humans.
Nephrol Dial Transplant.
1999;
14
641-647
-
8
Berger E D, Bader B D, Rüb N. et al .
Changes in renal and systemic
hemodynamics after NO-synthase inhibition in males with family history
of hypertension.
Kidney Blood Press Res.
2002;
25
42-49
-
9
Böger R H, Bode-Böger S M, Szuba A. et al .
Asymmetrical
dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction:
its role in hypercholesterolemia.
Circulation.
1998;
98
1842-1847
-
10
Bournier M, Pechère-Bertschi A, Nussberger J. et al .
Studies of the renal effects
of angiotensin II receptor blockade: The confounding factor of acute
water loading on the action of vasoactive systems.
Am
J Kidney Dis.
1995;
26
105-115
-
11
Broere A, van den Meiracker A H, Boomsma F. et al .
Human renal and systemic hemodynamic,
natriuretic, and neurohumoral responses to different doses of L-NAME.
Am
J Physiol.
1998;
275
F870-F877
-
12
Cole R B, Giangiacomo J, Ingelfinger J R. et al .
Measurement of renal function
without urine collection. A critical evaluation of the constant-infusion-technique
for determination of inulin and para-aminohippurate.
N
Engl J Med.
1972;
287
1109-1114
-
13
Delles C, Jacobi J, John S, Fleischmann I, Schmieder R E.
Effects
of enalapril and eprosartan on the renal vascular nitric oxide system
in human essential hypertension.
Kidney Int.
2002;
61
1462-1468
-
14
Delles C, Jacobi J, Schlaich M P, John S, Schmieder R E.
Assessment
of endothelial function of the renal vasculature in human subjects.
Am
J Hypertens.
2002;
15
3-9
-
15
Delles C, Klingbeil A U, Schneider M P, Handrock R, Schmieder R E.
Disparate effects of valsartan
vs. amlodipine on renal hemodynamics and endothelial function: a
double blind, randomized, controlled trial (Abstrakt).
Dtsch
Med Wochenschr.
2001;
126
(Suppl 3)
S158
-
16
Dijkhorst-Oei L T, Beutler J J, Stroes E S. et al .
Divergent effects
of ACE-inhibition and calcium channel blockade on NO-activity in
systemic and renal circulation in essential hypertension.
Cardiovasc
Res.
1998;
40
402-409
-
17
Egashira K, Suzuki S, Hirooka Y. et al .
Impaired endothelium-dependent vasodilation
in large epicardial and resistance coronary arteries in patients
with essential hypertension: different responses to acetylcholine
and substance P.
Hypertension.
1995;
25
201-206
-
18
Fleischmann E, Schlaich M P, Oehmer S, Schmieder R E.
Hypercholesterolemia and
treatments with statins do not alter L-arginine induced changes
of renal hemodynamics.
Nephrol Dial Transplant.
2002;
im Druck
-
19
Freed T A, Hager H, Vinik M.
Effects
of intra-arterial acetylcholine on renal arteriography in normal
humans.
Am J Roentenol Radium Ther Nucl Med.
1968;
104
312-318
-
20
Furchgott R F, Zawadzki J V.
The obligatory
role of endothelial cells in the relaxation of arterial smooth muscle
by acetylcholine.
Nature.
1980;
288
373-376
-
21
Goonasekera C D, Rees D D, Woolard P. et al .
Nitric oxide synthase inhibitors
and hypertension in children and adolescents.
J Hypertens.
1997;
15
901-909
-
22
Herlitz H, Jungersten L U, Wikstrand J, Widgren B R.
Effect
of L-arginine infusion in normotensive subjects with and without
a family history of hypertension.
Kidney Int.
1999;
56
1838-1845
-
23
Higashi Y, Chayama K.
Renal endothelial dysfunction
and hypertension.
J Diabetes Complications.
2002;
16
103-107
-
24
Higashi Y, Oshima T, Ozono R. et al .
Effects of L-arginine infusion on renal
hemodynamics in patients with mild essential hypertension.
Hypertension.
1995;
25
898-902
-
25
Higashi Y, Oshima T, Sasaki S. et al .
Angiotensin-converting enzyme inhibition, but
not calcium antagonism, improves a response of the renal vasculature
to L-arginine in patients with essential hypertension.
Hypertension.
1998;
32
16-24
-
26
Jacobi J, Schneider M P, John S, Schmieder R E.
Impact of
NO-synthase inhibition on renal hemodynamics in normotensive and
hypertensive subjects.
J Hypertens.
2002;
20
525-530
-
27
John S, Jacobi J, Delles C, Schaich M P, Schneider M P, Schmieder R E.
Rapid
improvement of nitric oxide bioavailability after lipid lowering
therapy with cerivastatin within two weeks.
J Am Coll
Cardiol.
2001;
37
1351-1358
-
28
Kawagishi T, Matsuyoshi M, Emoto M. et al .
Impaired endothelium-dependent vascular
responses of retinal and intrarenal arteries in patients with type
2 diabetes.
Arterioscler Thromb Vasc Biol.
1999;
19
2509-2516
-
29
Komers R, Komersova K, Kazdova L, Rizickova J, Pelikanova T.
Effect
of ACE inhibition and angiotensin AT1 receptor blockade on renal
and blood pressure response to L-arginine in humans.
J
Hypertens.
2000;
18
51-59
-
30
La Villa G, Barletta G, Pantaleo P. et al .
Hemodynamic, renal, and endocrine effects of
acute inhibition of nitric oxide synthase in compensated cirrhosis.
Hepatology.
2001;
34
19-27
-
31
Mayer B X, Mensik C, Krishnaswami S. et al .
Pharmacokinetic-pharmacodynamic profile
of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
Br J
Clin Pharmacol.
1999;
47
539-44
-
32
Mimran A, Ribstein J, DuCailar G.
Contrasting
effect of antihypertensive treatment on the renal response to L-arginine.
Hypertension.
1995;
26
937-941
-
33
Montanari A, Tateo E, Fasoli E. et al .
Angiotensin II blockade does not prevent
renal effects of L-NAME in sodium-repleted humans.
Hypertension.
1997;
30
557-562
-
34
Palmer R MJ, Ashton D S, Moncada S.
Vascular
endothelial cells synthesize nitric oxide from L-arginine.
Nature.
1988;
333
664-666
-
35
Panza J A, Casino P R, Badar D M, Quyyumi A A.
Effect
of increased availability of endothelium-derived nitric oxide precursor
on endothelium-dependent vascular relaxation in normal subjects
and in patients with essential hypertension.
Circulation.
1993;
87
1475-1481
-
36
Perinotto P, Biggi A, Carra N. et
al .
Angiotensin II and prostaglandin interactions on
systemic and renal effects of L-NAME in humans.
J Am Soc
Nephrol.
2001;
12
1706-1712
-
37
Raij L, Baylis C.
Glomerular actions of nitric
oxide.
Kidney Int.
1995;
48
20-31
-
38
Schlaich M P, Jacobi J, John S, Delles C, Fleischmann I, Schmieder R E.
Is L-arginine infusion
an adequate tool to assess endothelium-dependent vasodilation of
the human renal vasculature?.
Clin Sci (Colch).
2000;
99
293-302
-
39
Schmidt B MW, Delles C, Klingbeil A U, Schneider M P, John S, Schmieder R E.
Is basal
nitric oxide bioavailability similarly impaired in the forearm and
the renal vasculature? (Abstrakt).
Dtsch Med Wochenschr.
2001;
126
S185
(Suppl 3)
-
40
Schmieder R E, Delles C, Müller H J, Schneider M P, John S, Schulze B.
Analysis
of endothelial function in the human renal vasculature (Abstrakt).
J
Hypertens.
2002;
20
(Suppl
4)
S109
-
41
Schmieder R E, Gatzka C, Schobel H. et al .
Renal hemodynamic response to stress is
influenced by ACE-inhibitors.
Clin Nephrol.
1994;
42
381-388
-
42
Schmieder R E, Veelken R, Schobel H P. et al .
Glomerular hyperfiltration during sympathetic
nervous system activation in early essential hypertension.
J
Am Soc Nephrol.
1997;
8
893-900
-
43
Schneider M P, Klingbeil A U, Schmidt B MW, Fleischmann E, Schmieder R E.
Vitamin C augments the renal response
to L-arginine in smokers (Abstrakt).
J Am Soc Nephrol.
2001;
12
517
-
44
Segarra G, Medina P, Vila J M. et al .
Inhibition of nitric oxide activity by
arginine analogs in human renal arteries.
Am J Hypertens.
2001;
14
1142-1148
-
45
Spahr L, Martin P Y, Giostra E. et al .
Acute effects of nitric oxide synthase
inhibition on systemic, hepatic, and renal hemodynamics in patients
with cirrhosis and ascites.
J Investig Med.
2002;
50
116-124
-
46
Tangphao O, Grossmann M, Chalon S. et al .
Pharmacokinetics of intravenous and oral
L-arginine in normal volunteers.
Br J Clin Pharmacol.
1999;
47
261-266
-
47
Vallance P, Leone H, Calver A.
Accumulation
of an endogenous inhibitor of nitric oxide synthesis in chronic
renal failure.
Lancet.
1992;
339
572-575
-
48
Wierema T K, Houben A J, Kroon A A. et al .
Nitric oxide dependence
of renal blood flow in patients with renal artery stenosis.
J
Am Soc Nephrol.
2001;
12
1836-1843
-
49
Wolzt M, Schmetterer L, Ferber W. et al .
Effect of nitric oxide synthase inhibition on
renal hemodynamics in humans: reversal by L-arginine.
Am
J Physiol.
1997;
272
F178-F182
-
50
Zeiher A M, Drexler H, Saurbier B, Just H.
Endothelium-mediated coronary
blood flow modulation in humans. Effects of age, atherosclerosis,
hypercholesterolemia, and hypertension.
J Clin Invest.
1993;
92
652-662
Prof. Dr. med. Roland E. Schmieder
Medizinische Klinik IV/4, Universität
Erlangen-Nürnberg, Klinikum Nürnberg-Süd
Breslauer Straße 201
90471 Nürnberg
Phone: 0911/398-2702
Fax: 0911/398-3183
Email: roland.schmieder@rzmail.uni-erlangen.de
